The cardiorenal syndrome: making the connection

Gautham Viswanathan1, Scott Gilbert

  • 1Division of Nephrology, Tufts Medical Center, 800 Washington Street, P.O. 391, Boston, MA 02111, USA.

Insights

Cardiorenal syndrome (CRS) involves heart and kidney dysfunction. Type 1 CRS occurs when acute decompensated heart failure causes acute kidney injury due to reduced kidney filtration and perfusion.

Area of Science:

  • Cardiology
  • Nephrology
  • Physiology

Background:

  • The heart and kidneys are interdependent for maintaining hemodynamic stability and organ perfusion.
  • Underlying heart or kidney disease compromises the compensatory mechanisms between these organs.
  • This interaction has led to the characterization of cardiorenal syndrome (CRS).

Purpose of the Study:

  • To review cardiorenal syndrome (CRS), focusing on Type 1.
  • To examine the scope, impact, and pathophysiology of CRS Type 1.
  • To discuss diagnostic tools and therapeutic interventions for CRS Type 1.

Main Methods:

  • Review of existing literature on cardiorenal syndrome.
  • Analysis of the pathophysiology linking acute decompensated heart failure and acute kidney injury.
  • Synthesis of information on diagnostic and therapeutic strategies.

Main Results:

  • Acute decompensated heart failure (ADHF) can precipitate acute kidney injury (AKI) via hemodynamic and neurohormonal pathways.
  • Underperfusion and venous congestion are key pathophysiological mechanisms in CRS Type 1.
  • Early detection and intervention are crucial for managing CRS Type 1.

Conclusions:

  • CRS Type 1 represents a significant complication of acute decompensated heart failure.
  • Understanding the interplay between cardiac and renal systems is vital for effective management.
  • Further research into diagnostic and therapeutic strategies is warranted to improve patient outcomes.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...